Stocks & ETFs

US Dollar Firms up into NY Open

US Dollar Firms up into NY Open

October 17, 2017 at 1:46 pm 0 comments

The U.S. dollar firmed up into the New York open, with EUR/USD falling under 1.1810 on mixed reports that the European Central Bank may cut quantitative easing purchases levels, while extending the duration of the program. USD/JPY recovered the 112 handle after finding support into its 200-day moving average of 111.82. The U.S. calendar is headlined by September consumer priceRead More

Opko Health Strikes Deal For Japan Tobacco to Develop

Opko Health Strikes Deal For Japan Tobacco to Develop

October 16, 2017 at 2:59 pm 0 comments

Opko Health Inc (OPK) shares were higher nearly 2% in recent pre-market trading after the company said it has struck a deal with Japan Tobacco to develop and commercialize its Rayaldee in Japan for treatment of secondary hyperparathyroidism in non-dialysis and dialysis patients with chronic kidney disease. Under the terms, Japan Tobacco will pay an upfront payment of $6 million.Read More

Hourly Earnings Surge as Payrolls Drop 33,000 vs +100,000 Expected

Hourly Earnings Surge as Payrolls Drop 33,000 vs +100,000 Expected

October 10, 2017 at 9:06 pm 0 comments

U.S. nonfarm payrolls fell 33,000 in September versus the 100,000 increase expected, with August revised to 169,000 from 156,000 previously but July lowered to 138,000 from 189,000. That left the 3-month average at 91,000. The unemployment rate dropped to 4.2% from 4.4% (consensus: 4.4%). Hourly earnings surged 0.5% versus the 0.3% expected, from August’s 0.2% gain (revised higher from 0.1%).Read More

RBC Raises Costco PT to $190 on Q4 EPS Beat

RBC Raises Costco PT to $190 on Q4 EPS Beat

October 10, 2017 at 9:02 pm 0 comments

Costco Wholesale (COST) has had its price target raised by analysts at RBC to $190 from $184 on better-than-expected Q4 results. The firm maintained its outperform rating on the stock. Shares of Costco are down 3% in pre-market trading. In a note to clients, RBC said Costco’s sales and traffic remain “solid and consistent,” and cited traffic growth of “aRead More

Medicines Co. Price Target Boosted by Chardan to $85 From $80, Buy Rating Maintained

Medicines Co. Price Target Boosted by Chardan to $85 From $80, Buy Rating Maintained

August 30, 2017 at 2:10 pm 0 comments

Medicines Co. (MDCO) received a price-target boost Tuesday from Chardan Capital Markets following the biopharmaceutical company’s Monday release with partner Alnylam Pharmaceuticals (ALNY) of an encouraging update on their phase 2 trial of inclisiran in hypercholesterolemia. The new price target from Chardan is $85 per share, up from $80 and well above the stock’s Monday closing price of $37.72. ChardanRead More

Pacira Pharmaceuticals Upgraded by Janney

Pacira Pharmaceuticals Upgraded by Janney

August 21, 2017 at 11:58 am 0 comments

Pacira Pharmaceuticals received an investment-rating upgrade Monday to neutral from sell from Janney Montgomery Scott as the firm noted a nearly 30% decline in the pharmaceutical company’s stock over the past month has brought it near the firm’s fair-value estimate of $36 each. Janney said its sell rating on the stock had been based on the belief it was “wayRead More

Rada Electronics Industries Awarded Contract

Rada Electronics Industries Awarded Contract

August 16, 2017 at 10:26 am 0 comments

Rada Electronics Industries said it has received a strategic first order for dozens of Multi-Mission Hemispheric Radars (MHR) for more than $8 million. The radars will be used by the U.S. military, providing it with air surveillance with emphasis on counter-unmanned aerial vehicles (UAV). The radars are expected to be fielded for operational use soon after delivery, which will takeRead More